Showing 1,121 - 1,140 results of 8,597 for search 'effective dysfunction', query time: 0.15s Refine Results
  1. 1121
  2. 1122
  3. 1123
  4. 1124

    PACAP/PAC1 regulation in cystitis rats: induction of bladder inflammation cascade leading to bladder dysfunction by Hanwei Ke, Hanwei Ke, Lin Zhu, Weiyu Zhang, Weiyu Zhang, Huanrui Wang, Huanrui Wang, Zehua Ding, Zehua Ding, Dongyu Su, Dongyu Su, Qi Wang, Qi Wang, Kexin Xu, Kexin Xu

    Published 2024-11-01
    “…Transcriptomic analysis, immunohistochemistry, and bladder function assays were employed to assess the correlation between PACAP/PAC1 activation, bladder inflammation, and sensory dysfunction. Additionally, modulation of the PACAP/PAC1 pathway was tested in rats to determine its effects on bladder inflammation and function.ResultsOur results demonstrate significant upregulation of PACAP and PAC1 in both human bladder tissues from IC/BPS patients and in the rat cystitis model. …”
    Get full text
    Article
  5. 1125

    Sex and region-specific disruption of autophagy and mitophagy in Alzheimer’s disease: linking cellular dysfunction to cognitive decline by Aida Adlimoghaddam, Fariba Fayazbakhsh, Mohsen Mohammadi, Zeinab Babaei, Amir Barzegar Behrooz, Farhad Tabasi, Teng Guan, Iman Beheshti, Mahmoud Aghaei, Daniel J. Klionsky, Benedict C. Albensi, Saeid Ghavami

    Published 2025-04-01
    “…Cognitive deficits in females correlated with mitochondrial dysfunction in the cortex, while in males, higher LC3B-II levels associated positively with cognitive performance, suggesting protective autophagy effects. …”
    Get full text
    Article
  6. 1126
  7. 1127
  8. 1128
  9. 1129

    Macrophage Notch1 drives septic cardiac dysfunction by impairing mitophagy and promoting NLRP3 activation by Yanjun Zheng, Jingrong Lin, Guoqing Wan, Xuefeng Gu, Jian Ma

    Published 2025-05-01
    “…Moreover, LPS induced mitophagy, an effect that was further enhanced by Notch1 knockout. …”
    Get full text
    Article
  10. 1130

    Low-intensive Laser Therapy for Management of Cerebral Dysfunction in Patients with Obstructive Jaundice of Non-tumor Origin by A. P. Vlasov, I. A. Chigakova, D. E. Timoshkin, M. A. Spirina, V. S. Kuznetsov, N. S. Sheyranov, A. V. Rubtsov

    Published 2019-04-01
    “…On check dates (day 1 and 7), the severity of cerebral dysfunction was assessed in all patients using the psychometric tests (“Point in Circle, “Labyrinth”). …”
    Get full text
    Article
  11. 1131
  12. 1132

    Metabolic dysfunction-associated fatty liver disease and risk of nephrolithiasis: a sizeable cross-sectional study by Shengqi Zheng, Tianchi Hua, Guicao Yin, Wei Zhang, Xiaoxiang Wang, Lezhong Qi, Xiayong Jing, Qibing Fan, Xiaoping Yu, Yifan Li

    Published 2025-01-01
    “…ObjectiveMetabolic dysfunction-associated fatty liver disease (MAFLD) and nephrolithiasis are two common metabolic diseases, but their relationship has not yet been thoroughly studied. …”
    Get full text
    Article
  13. 1133

    Prevalence of renal dysfunction and its influence on functional capacity in elderly patients with stable chronic heart failure by Stanojević Dragana, Apostolović Svetlana, Janković-Tomašević Ružica, Šalinger-Martinović Sonja, Pavlović Milan, Živković Milan, Božinović Nenad, Kutlešić-Kurtović Dušanka

    Published 2012-01-01
    “…In spite of a large number of pharmacological agents that successfully decrease mortality in CHF, the effects on exercise tolerance and quality of life are modest. …”
    Get full text
    Article
  14. 1134

    Green tea epigallocatechin gallate attenuate metabolic dysfunction-associated steatotic liver disease by regulation of pyroptosis by Jie Zhang, Shuangshuang Wang, Ting Zhang, Minghui Zi, Shuxiang Wang, Qiao Zhang

    Published 2025-05-01
    “…Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most common chronic liver disease, with other fat-liver diseases potentially progressing to cirrhosis and hepatocellular carcinoma. …”
    Get full text
    Article
  15. 1135

    Correction of renal dysfunction under the influence of dietary management, exercises and lisinopril in patients with abdominal obesity and hypertension. by M. K. Rokutova

    Published 2015-11-01
    “…The purpose of research is to assess the impact of diet therapy, physical activity and an ACE inhibitor (lisinopril) on renal dysfunction in patients with abdominal obesity and hypertension. …”
    Get full text
    Article
  16. 1136

    Interaction between post-tumor inflammation and vascular smooth muscle cell dysfunction in sepsis-induced cardiomyopathy by Rui Liu, Lina Jia, Lin Yu, Detian Lai, Qingzhu Li, Bingyu Zhang, Enwei Guo, Kailiang Xu, Qiancheng Luo

    Published 2025-04-01
    “…While its clinical relevance is well-documented, the intricate molecular mechanisms that link sepsis, tumor-driven inflammation, and cardiac dysfunction remain inadequately explored. This study aims to elucidate the interaction between post-tumor inflammation, intratumor heterogeneity, and the dysfunction of VSMC in SIC, as well as to evaluate the therapeutic potential of exercise training and specific pharmacological interventions.MethodsTranscriptomic data from NCBI and GEO databases were analyzed to identify differentially expressed genes (DEGs) associated with SIC. …”
    Get full text
    Article
  17. 1137

    Correction of renal dysfunction under the influence of dietary management, exercises and lisinopril in patients with abdominal obesity and hypertension by Rokutova М.К.

    Published 2015-11-01
    “…The purpose of research is to assess the impact of diet therapy, physical activity and an ACE inhibitor (lisinopril) on renal dysfunction in patients with abdominal obesity and hypertension. …”
    Get full text
    Article
  18. 1138

    Using a magnetic posture corrector in therapy of somatoform autonomic dysfunction in patients with chronic spinal diseases by R. M. Gafurova, E. R. Makhmudova, R. G. Khabchabov, A. A. Abdullaev, U. A. Islamova, A. A. Anatova, M. A. Dzhanbulatov

    Published 2025-02-01
    “…Somatoform autonomic dysfunction (SAD) can aggravate an existing disease or be combined with other mental disorders (e.g., depression, anxiety, and hypochondria). …”
    Get full text
    Article
  19. 1139

    Rapid Replenishment of Phylloquinone in the Plasma and Liver Using Hyaluronan-Based Nanocapsules Reverses Endothelial Dysfunction in Mice by Kieronska-Rudek A, Kij A, Bar A, Sternak M, Paterek A, Rolski F, Czyzynska-Cichon I, Fedak FA, Wojnar-Lason K, Bednorz J, Janik-Hazuka M, Kostogrys RB, Franczyk-Zarow M, Czyżowska KZ, Michalkova L, Mączewski M, Zapotoczny S, Kus E, Chlopicki S

    Published 2025-06-01
    “…Importantly, 7-day PK-Oil-HyC12 supplementation restored impaired endothelium-dependent vasodilation in the aorta of PK-deficient mice, while PK-Oil was ineffective.Conclusion: The improved bioavailability of PK, when administered in the form of hyaluronan-based nanocapsules, afforded the rapid replenishment of systemic PK and the reversal of endothelial dysfunction induced by low PK levels. Keywords: Vitamin K1, phylloquinone, hyaluronan-based nanocapsules, endothelial dysfunction, dietary phylloquinone deficiency…”
    Get full text
    Article
  20. 1140

    Elevated levels of Letm1 drives mitochondrial dysfunction and cardiomyocyte stress-mediated apoptosis in cultured cardiomyocytes by Anushka Deshpande, Leo Weirauch, Tapan Kumar Baral, Marco Steier, Ankush Borlepawar, Manju Kumari, Lucia S. Kilian, Karsten Richter, Elke Hammer, Derk Frank, Constanze Schmidt, Norbert Frey, Ashraf Y. Rangrez

    Published 2025-08-01
    “…Abstract Background Cardiac ischemia, a predominant cause of heart failure, is marked by profound mitochondrial dysfunction, dysregulated ion homeostasis, and maladaptive cellular remodeling, all of which compromise cardiac performance. …”
    Get full text
    Article